Instrument Inactif

Communiqués Vitality Biopharma, Inc. Other OTC

Actions

VBIO

US92849B1070

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Range Impact Reports 1Q 2024 Financial Results	15/05	AQ
Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer	26/04	AQ
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results	29/03	AQ
Range Impact Announces Former Ohio Congressman Zack Space and Former Ohio Senator Jay Hottinger Have Joined the Company as Strategic Advisors	29/01	AQ
Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors	21/12	AQ
Malachite Innovations Changes its Name to Range Impact and Adopts New Ticker Symbol “RNGE”	14/12	AQ
Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business	07/12	AQ
MALACHITE INNOVATIONS REPORTS THIRD QUARTER 2023 RESULTS	14/11	AQ
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $1.0 MILLION CAPITAL RAISE TO FUND FIRST ACQUISITION OF FORMER MINE LAND	15/09/23	AQ
MALACHITE INNOVATIONS ANNOUNCES CLOSING THE ACQUISITION OF ITS THIRD RECLAMATION BUSINESS IN WEST VIRGINIA	05/09/23	AQ
MALACHITE INNOVATIONS REPORTS SECOND QUARTER 2023 RESULTS	01/08/23	AQ
MALACHITE INNOVATIONS : REPORTS SECOND QUARTER 2023 RESULTS - Form 8-K	01/08/23	PU
MALACHITE INNOVATIONS AND ITS SUBSIDIARY GRAPHIUM BIOSCIENCES RELEASE NEW INVESTOR PRESENTATIONS AND ANNOUNCE UPCOMING FUNDRAISING EFFORTS	01/06/23	AQ
MALACHITE INNOVATIONS ANNOUNCES CONTINUED EXPANSION OF ITS SENIOR LEADERSHIP TEAM WITH THREE NEW ADDITIONS	01/06/23	AQ
MALACHITE INNOVATIONS REPORTS FIRST QUARTER 2023 RESULTS	31/05/23	AQ
MALACHITE INNOVATIONS ANNOUNCES ENGAGEMENT WITH SUNDAY CREEK HORIZONS, AN APPALACHIAN-FOCUSED CONSULTING FIRM	16/05/23	AQ
MALACHITE INNOVATIONS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)	13/04/23	AQ
MALACHITE INNOVATIONS ANNOUNCES CAPITAL RAISE LED BY BERNIE KOSAR, EDWARD FEIGHAN AND TWO OUTSIDE PRIVATE INVESTMENT FIRMS	13/04/23	AQ
2022 ANNUAL REPORT HIGHLIGHTS	06/04/23	AQ
MALACHITE INNOVATIONS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations." (form 10-K)	31/03/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Vitality Biopharma, Inc. Other OTC

Actions

VBIO

US92849B1070

Communiqués

Filtres